In a recent study led by Catherine Gibbons from the University of Leeds, the effects of sweetener reformulated biscuits on appetite and endocrine responses in adults with overweight or obesity were evaluated. This study, conducted between 2021 and 2022 in England and France, sheds light on the potential benefits of substituting sucrose with sweeteners like neotame and stevia rebaudioside M (StRebM).
The findings suggest that while the reformulated biscuits yielded similar appetite responses compared to sucrose-sweetened ones, they demonstrated a significant advantage in terms of post-meal insulin and glucose levels. Participants consuming biscuits with neotame and StRebM experienced lower postprandial insulin levels compared to those consuming sucrose, indicating a potential positive impact on blood glucose control. This is particularly noteworthy in the context of individuals at risk of developing type 2 diabetes.
However, it's essential to acknowledge the limitations highlighted in the study. The inclusion of polyol bulking agents in the reformulated products may have contributed to gastrointestinal symptoms reported by some participants. This aspect underscores the need for further research to explore the tolerability and long-term effects of such formulations.
Moreover, the study's disclosures indicate funding from various entities, including the food and beverage industry and trade groups. While this does not necessarily invalidate the findings, it's crucial to consider potential biases and conflicts of interest that may arise from industry involvement.
Overall, the study provides valuable insights into the potential role of sweetener reformulated products in managing blood glucose levels, but further research is warranted to address lingering questions regarding gastrointestinal effects and long-term implications.
The findings suggest that while the reformulated biscuits yielded similar appetite responses compared to sucrose-sweetened ones, they demonstrated a significant advantage in terms of post-meal insulin and glucose levels. Participants consuming biscuits with neotame and StRebM experienced lower postprandial insulin levels compared to those consuming sucrose, indicating a potential positive impact on blood glucose control. This is particularly noteworthy in the context of individuals at risk of developing type 2 diabetes.
However, it's essential to acknowledge the limitations highlighted in the study. The inclusion of polyol bulking agents in the reformulated products may have contributed to gastrointestinal symptoms reported by some participants. This aspect underscores the need for further research to explore the tolerability and long-term effects of such formulations.
Moreover, the study's disclosures indicate funding from various entities, including the food and beverage industry and trade groups. While this does not necessarily invalidate the findings, it's crucial to consider potential biases and conflicts of interest that may arise from industry involvement.
Overall, the study provides valuable insights into the potential role of sweetener reformulated products in managing blood glucose levels, but further research is warranted to address lingering questions regarding gastrointestinal effects and long-term implications.
Comments
Post a Comment